SOMERSET, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced that the Company will attend the HFMA Revenue Cycle Conference in Arlington, Texas, where it will showcase the continued evolution of MAP App, its web-based revenue cycle benchmarking. CareCloud will also host a networking happy hour during the conference and offer a live webinar for those unable to attend in pers ...

SOMERSET, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced that the Company will attend the HFMA Revenue Cycle Conference in Arlington, Texas, where it will showcase the continued evolution of MAP App, its web-based revenue cycle benchmarking. CareCloud will also host a networking happy hour during the conference and offer a live webinar for those unable to attend in pers ...

SOMERSET, N.J., March 17, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced that the Company will participate in the 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum on Tuesday, March 17, 2026. Company executives will participate in a fireside chat as part of the forum. The session will be streamed live to registered attendees of the conference. A replay will subsequently be ma ...

SOMERSET, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and revenue cycle management solutions, today announced that the Company will ring the Nasdaq Closing Bell on Tuesday, May 19, 2026, at the Nasdaq MarketSite in New York City. The event will coincide with CareCloud’s 2026 Analyst Day, which will be hosted at the Nasdaq building in Times Square. The event comes at a pivotal moment for CareCloud, ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors rely on traditional forms of a ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark one) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36529 CareCloud, Inc. (Exact name of registrant as specified in its charter) Delaware 22-3832302 (State or other jurisdiction of inc ...

分组1 - CareCloud, Inc. reported quarterly earnings of $0.11 per share, matching the Zacks Consensus Estimate, but down from $0.23 per share a year ago [1] - The company posted revenues of $34.42 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 5.30%, compared to $28.24 million in the same quarter last year [2] - CareCloud has surpassed consensus revenue estimates three times over the last four quarters [2] 分组2 - The stock has declined approximately 8.9% since the beginning of the year, while the S&P 500 has only declined by 1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.06 on revenues of $31.78 million, and for the current fiscal year, it is $0.42 on revenues of $130.33 million [7] - The Zacks Industry Rank for Medical Info Systems is in the bottom 41% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Core Insights - CareCloud resumed dividends on preferred shares in 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 to address arrearages [1] - The company converted approximately 80% of Series A preferred shares into common stock in 2025, eliminating over $7 million in annual dividend obligations [1] Financial Performance - Non-GAAP free cash flow was $20.5 million in 2025, a 55% increase from $13.2 million in 2024, indicating improved financial flexibility [2] - GAAP operating cash flow reached $28.6 million in 2025, up 38% year over year, with $8.7 million generated in Q4, a 66% increase [3] - Adjusted EBITDA for the full year was $27.5 million, representing a 23% margin, and increased 15% from $24.1 million in 2024 [4] - GAAP net income for 2025 was $10.8 million, up over 37% year over year, marking the first full year of positive EPS since the 2014 IPO [6] Revenue Growth - Full-year revenue for 2025 was $120.5 million, up nearly 9% year over year, with Q4 revenue at $34.4 million, a nearly 22% increase from the prior year [7] - CareCloud raised revenue guidance twice in 2025 and exceeded its final target [7] Strategic Acquisitions - CareCloud completed multiple acquisitions in 2025, funded entirely through free cash flow, resulting in no common shareholder dilution [10] - The acquisition of Medsphere Systems expanded CareCloud's reach into the inpatient hospital market and added new software products [11] - The fourth-quarter revenue included approximately $7.2 million related to the Medsphere acquisition [12] AI Initiatives - CareCloud launched an AI Center of Excellence in April 2025, focusing on integrating AI solutions into healthcare workflows [14] - The flagship AI product, stratusAI Desk Agent, was fully released in December 2025, handling various administrative tasks [15] - AI tools are being utilized to improve revenue cycle management operations, aiming for "zero touch claims" with minimal human intervention [17] 2026 Guidance - For 2026, CareCloud guided revenue of $128 million to $130 million and adjusted EBITDA of $29 million to $31 million, reflecting margin expansion [19] - GAAP EPS is expected to be between $0.20 and $0.23, representing an increase of over 100% from 2025 [19] Market Position - CareCloud's healthcare IT solutions are supported by over 25 years of proprietary data, providing a competitive advantage in the industry [21] - The company serves small to mid-size physician groups and specialty clinics across the United States, enhancing operational efficiency through its cloud-based platform [23][24]

Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth [7] - In Q4 2025, revenue reached $34.4 million, up nearly 22% year-over-year, indicating accelerating momentum [7] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10 [7] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [8] - Free cash flow for 2025 reached approximately $20.5 million, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [8] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [10] - The integration of AI tools into the platform has already resulted in new customer wins under the CareCloud umbrella [11] - The company aims to penetrate newly acquired health system customers with its RCM and AI products as part of its 2026 growth strategy [12] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment [12] - The company recognizes a multi-billion-dollar addressable opportunity in the U.S. for its AI front desk assistant [12] Company Strategy and Development Direction - The company’s 2026 growth strategy focuses on leveraging its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [13] - Strategic acquisitions have been a cornerstone of growth, with a disciplined approach to acquiring companies at attractive valuations [14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million to $130 million for 2026, with adjusted EBITDA of $29 million to $31 million [15] - The company anticipates GAAP EPS of $0.20 to $0.23 per share, representing an increase of more than 100% over 2025 [15] - Management highlighted the importance of disciplined execution, innovation, and creating long-term value for stakeholders [35] Other Important Information - The company resumed dividends on its preferred shares at the beginning of 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 [9] - The conversion of approximately 80% of Series A preferred shares into common eliminated more than $7 million in annual dividend obligations [9] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms, enhancing their attractiveness and market position [38][41] Question: What was behind the recent contract wins with new customers? - Management noted the expansion of the sales and marketing team and the focus on cross-selling and upselling existing customers, particularly those acquired through recent transactions [45][46] Question: How should investors think about CareCloud's exposure to AI disruption? - Management emphasized that the company operates in a niche healthcare IT space with deep industry moats, making it less vulnerable to generic AI disruptions [54][56] Question: What are the focuses for the use of excess cash flow? - Management indicated that the focus would be on acquisitions, enhancing the capital structure, and investing in AI development [73] Question: Who are the company's main competitors? - Management identified competitors in the EHR space such as eClinicalWorks and athenahealth, and noted that the AI competitive landscape is broader, with some players lacking a vertical approach [75][78]

Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth [7] - In Q4 2025, revenue reached $34.4 million, up nearly 22% year-over-year, indicating accelerating momentum [7] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10 [7] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [8] - Free cash flow reached approximately $20.5 million for 2025, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [8] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [10] - The integration of AI tools into the platform has already resulted in new customer wins under the CareCloud umbrella [11] - The company aims to penetrate newly acquired health system customers with its RCM and AI products as part of its 2026 growth strategy [12] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment [12] - The company recognizes a multi-billion-dollar addressable opportunity in the U.S. for its AI front desk assistant [12] Company Strategy and Development Direction - The company’s 2026 growth strategy focuses on leveraging its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [13] - Strategic acquisitions have been a cornerstone of growth, with a disciplined approach to acquiring companies at attractive valuations [14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million-$130 million for 2026, with adjusted EBITDA of $29 million-$31 million [15] - The company anticipates GAAP EPS of $0.20-$0.23 per share, representing an increase of more than 100% over 2025 [15] - Management highlighted the importance of disciplined execution and innovation to create long-term value for stakeholders [35] Other Important Information - The company resumed dividends on its preferred shares at the beginning of 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 [9] - The conversion of approximately 80% of Series A preferred shares into common eliminated more than $7 million in annual dividend obligations [9] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms to enhance their attractiveness and market position [38][41] Question: What was behind the recent contract wins and future opportunities? - Management noted the expansion of the sales team and the focus on cross-selling additional services to existing clients acquired through recent transactions [45][46] Question: How does CareCloud's exposure to AI disruption compare to being an AI beneficiary? - Management emphasized that CareCloud operates in a niche healthcare IT space with deep industry moats, making it less vulnerable to generic AI disruptions [54][56] Question: What are the focuses for the use of excess cash flow? - Management indicated that the focus would be on acquisitions, enhancing capital structure, and investing in AI development [73] Question: Who are CareCloud's main competitors? - Management identified competitors in the EHR space such as eClinicalWorks and athenahealth, and noted that the AI competitive landscape varies depending on the product [75][76]